Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis

References

• WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020; 2020. Available from: https://www.who.int/dg/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-mediabriefing-on-covid-19-11-march-2020. Accessed April 08, 2020.
   Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017
   PubMed Web of Science ®Google Scholar
• Tootee A, Esfahani EN, Larijani B. Diabetes management during Ramadan amid Covid-19 pandemic. DARU J Pharm Sci. 2020. doi:10.1007/s40199-020-00357-6
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. China medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020;30(8):1236–1248. doi:10.1016/j.numecd.2020.05.014
   PubMed Web of Science ®Google Scholar
• WHO. Coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int. Accessed July 21, 2020.
   Google Scholar
• IDF Diabetes atlas, 9th edition 2019. Available from: https://www.diabetesatlas.org. Accessed July 21, 2020.
   Google Scholar
• Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020. doi:10.1016/s2213-8587(20)
   Google Scholar
• Wang Q, Fang P, He R, et al. O-GlcNAc transferase promotes influenza A virus–induced cytokine storm by targeting interferon regulatory factor–5. Sci Adv. 2020;6:13. doi:10.1126/sciadv.aaz7086
   Google Scholar
• Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813–821. doi:10.1177/1932296820924469
   PubMedGoogle Scholar
• Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4. doi:10.1172/jci.insight.131774.
   PubMedGoogle Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Shojaei A, Salari P. COVID-19 and off label use of drugs: an ethical viewpoint. Daru. 2020;1–5. doi:10.1007/s40199-020-00351-y
   PubMedGoogle Scholar
• Ayati N, Saiyarsarai P, Nikfar S. Short and long term impacts of COVID-19 on the pharmaceutical sector. Daru. 2020;1–7. doi:10.1007/s40199-020-00358-5
   PubMedGoogle Scholar
• Rahimi R, Nikfar SH, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59:365–373. doi:10.1016/j.biopha.2005.07.002
   PubMed Web of Science ®Google Scholar
• Wu YH, Tseng CP, Cheng ML, et al. Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis. 2008;197:812e816. doi:10.1086/528377
   Google Scholar
• Li Y, Liu B, Cui J, et al. Similarities and evolutionary relationships of COVID-19 and related viruses. arXiv. 2020;2003:05580.
   Google Scholar
• Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235e49. doi:10.1016/j.cell.2008.02.043
   Google Scholar
• Zhong X, Chen B, Yang L, Yang Z. Molecular and physiological roles of the adaptor protein CARD9 in immunity. Cell Death Dis. 2018;9:52. doi:10.1038/s41419-017-0084-6
   PubMedGoogle Scholar
• Khomich OA, Kochetkov SN, Bartosch B, et al. Redox biology of respiratory viral infections. Viruses. 2018;10:E392. doi:10.3390/v10080392
   PubMed Web of Science ®Google Scholar
• van den Brand JMA, Haagmans BL, van Riel D, et al. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol. 2014;151:83e112. doi:10.1016/j.jcpa.2014.01.004
   Google Scholar
• Lin CW, Lin KH, Hsieh TH, et al. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol. 2006;46:375e380. doi:10.1111/j.1574-695X.2006.00045.x
   Google Scholar
• Bule M, Abdurahman A, Nikfar S, et al. Antidiabetic effect of quercetin: a systematic review and meta-analysis of animal studies. Food Chem Toxicol. 2019;125:494–502. doi:10.1016/j.fct.2019.01.037
   PubMed Web of Science ®Google Scholar
• Tabatabaei-Malazy O, Larijani B, Abdollahi M. A systematic review of in vitro studies conducted on effect of herbal products on secretion of insulin from Langerhans islets. J Pharm Pharm Sci. 2012;15(3):447–466. doi:10.18433/J32W29
   PubMedGoogle Scholar
• Naseri R, Farzaei F, Fakhri S, et al. Polyphenols for diabetes associated neuropathy: pharmacological targets and clinical perspective. Daru. 2019;27(2):781–798. doi:10.1007/s40199-019-00289-w
   PubMed Web of Science ®Google Scholar
• Macready AL, George TW, Chong MF, et al. Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease–FLAVURS: a randomized controlled trial. Am J Clin Nutr. 2014;99:479–489. doi:10.3945/ajcn.113.074237
   PubMedGoogle Scholar
• Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp. 2007;22:287–293.
   PubMed Web of Science ®Google Scholar
• Bahramsoltani R, Sodagari HR, Farzaei MH, et al. The preventive and therapeutic potential of natural polyphenols on influenza. Expert Rev Anti Infect Ther. 2016;14:57–80. doi:10.1586/14787210.2016.1120670
   PubMed Web of Science ®Google Scholar
• Lin LT, Hsu WC, Lin CC. Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014;4:24–35. doi:10.4103/2225-4110.124335
   PubMedGoogle Scholar
• Zu M, Yang F, Zhou W, et al. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives. Antiviral Res. 2012;94:217–224. doi:10.1016/j.antiviral.2012.04.001
   PubMed Web of Science ®Google Scholar
• Azadmehr A, Hajiaghaee R, Zohal MA, Maliji G. Protective effects of Scrophularia striata in Ovalbumin-induced mice asthma model. Daru. 2013;21(1):56. doi:10.1186/2008-2231-21-56
   PubMedGoogle Scholar
• Wu W, Li R, Li X, et al. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses. 2015;8(1):pii: E6. doi:10.3390/v8010006
   PubMedGoogle Scholar
• Nguyen TT, Woo HJ, Kang HK, et al. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett. 2012;34:831–838. doi:10.1007/s10529-011-0845-8
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi:10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299. doi:10.1111/j.1440-1681.2011.05648.x
   PubMed Web of Science ®Google Scholar
• Wen CC, Kuo YH, Jan JT, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50:4087–4095. doi:10.1021/jm070295s
   PubMed Web of Science ®Google Scholar
• Ciavarella C, Motta I, Valente S, et al. Pharmacological (or synthetic) and nutritional agonists of PPAR-γ as candidates for cytokine storm modulation in COVID-19 disease. Molecules. 2020;25:E2076. doi:10.3390/molecules25092076
   PubMed Web of Science ®Google Scholar
• Panahi Y, Hosseini MS, Khalili N, et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr. 2015;34:1101–1108. doi:10.1016/j.clnu.2014.12.019
   PubMed Web of Science ®Google Scholar
• Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res. 2004;18:592–594. doi:10.1002/ptr.1485
   PubMed Web of Science ®Google Scholar
• Yang Y, Islam MS, Wang J, et al. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16(10):1708–1717. doi:10.7150/ijbs.45538
   PubMed Web of Science ®Google Scholar